(Q42831055)

8 November 2017

title

Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas (English)

1 reference

8 November 2017

0 references

M Chen

1

1 reference

8 November 2017

L Rahman

2

1 reference

8 November 2017

D Voeller

3

1 reference

8 November 2017

E Kastanos

4

1 reference

8 November 2017

S X Yang

5

1 reference

8 November 2017

L Feigenbaum

6

1 reference

8 November 2017

C Allegra

7

1 reference

8 November 2017

F J Kaye

8

1 reference

8 November 2017

P Steeg

9

1 reference

8 November 2017

M Zajac-Kaye

10

1 reference

8 November 2017

language of work or name

English

0 references

publication date

12 February 2007

1 reference

8 November 2017

1 reference

8 November 2017

volume

26

1 reference

8 November 2017

issue

33

1 reference

8 November 2017

page(s)

4817-4824

1 reference

The N-Terminal Domain of c-Myc Associates with α-Tubulin and Microtubules In Vivo and In Vitro

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Of mice and MEN1: Insulinomas in a conditional mouse knockout

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Quantitation of thymidylate synthase in human tumors using an ultrasensitive enzyme-linked immunoassay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Multiple genetic alterations in malignant metastatic insulinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Prognostic importance of thymidylate synthase expression in early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Cooperative tumorigenic effects of germline mutations in Rb and p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210273

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210273

1 reference

Dimensions Publication ID

8 November 2017

1035789857

0 references

1 reference